Na/K-ATPase signaling regulates collagen synthesis through microRNA-29b-3p in cardiac fibroblasts

Physiological Genomics

Volumn 48, Issue 3, 2016, Pages 220-229

  Drummond, Christopher A ^a   Hill, Michael C ^a   Shi, Huilin ^a   Fan, Xiaoming ^a   Xie, Jeffrey X ^a   Haller, Steven T ^a   Kennedy, David J ^a   Liu, Jiang ^b   Garrett, Michael R ^c   Xie, Zijian ^d   Cooper, Christopher J ^a   Shapiro, Joseph I ^b   Tian, Jiang ^a  

^a MEDICAL COLLEGE OF OHIO   (United States)

^b MARSHALL UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c UNIVERSITY OF MISSISSIPPI MEDICAL CENTER   (United States)

^d MARSHALL UNIVERSITY   (United States)

Author keywords

Cardiovascular disease; Chronic kidney disease; Fibrosis; MicroRNA (miRNA); Na K ATPase

Indexed keywords

ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); MARINOBUFAGENIN; MICRORNA; MICRORNA 29B 3P; OUABAIN; STEROID; UNCLASSIFIED DRUG; BUFADIENOLIDE DERIVATIVE; CARDIOTONIC AGENT; COLLAGEN; MIRN29 MICRORNA, RAT;

ADULT; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; COLLAGEN SYNTHESIS; CONTROLLED STUDY; ENZYME INHIBITION; HEART FIBROBLAST; HEART MUSCLE FIBROSIS; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIMARY CULTURE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN TARGETING; RAT; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; ANIMAL; BIOSYNTHESIS; CARDIAC MUSCLE; CELL CULTURE; DOWN REGULATION; DRUG EFFECTS; FIBROBLAST; FIBROSIS; GENE EXPRESSION PROFILING; GENETIC TRANSFECTION; GENETICS; HEART VENTRICLE; METABOLISM; NEPHRECTOMY; PATHOLOGY; SPRAGUE DAWLEY RAT;

ANIMALS; BUFANOLIDES; CARDIOTONIC AGENTS; CELLS, CULTURED; COLLAGEN; DOWN-REGULATION; FIBROBLASTS; FIBROSIS; GENE EXPRESSION PROFILING; HEART VENTRICLES; MALE; MICRORNAS; MYOCARDIUM; NEPHRECTOMY; OUABAIN; RATS, SPRAGUE-DAWLEY; SIGNAL TRANSDUCTION; SODIUM-POTASSIUM-EXCHANGING ATPASE; STEROIDS; TRANSFECTION;

EID: 84984861213     PISSN: 10948341     EISSN: 15312267     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00116.2015     Document Type: Article

References (53)

1. Abe W, Nasu K, Nakada C, Kawano Y, Moriyama M, Narahara H. miR-196b targets c-myc and Bcl-2 expression, inhibits proliferation and induces apoptosis in endometriotic stromal cells. Hum Reprod 28: 750-761, 2013.
2. Brilla CG, Funck RC, Rupp H. Lisinopril-mediated regression of myocardial fibrosis in patients with hypertensive heart disease. Circulation 102: 1388-1393, 2000.
3. Cakmak HA, Coskunpinar E, Ikitimur B, Barman HA, Karadag B, Tiryakioglu NO, Kahraman K, Vural VA. The prognostic value of circulating microRNAs in heart failure: preliminary results from a genome- wide expression study. J Cardiovasc Med 16: 431-437, 2015.
4. Cao J, Zhang K, Zheng J, Dong R. MicroRNA-146a and -21 cooperate to regulate vascular smooth muscle cell proliferation via modulation of the Notch signaling pathway. Mol Med Rep 11: 2889-2895, 2015.
5. Chen P, Guo X, Zhou H, Zhang W, Zeng Z, Liao Q, Li X, Xiang B, Yang J, Ma J, Zhou M, Peng S, Xiang J, Li X, LEC, Xiong W, McCarthy JB, Li G. SPLUNC1 regulates cell progression and apoptosis through the miR-141-PTEN/p27 pathway, but is hindered by LMP1. PLoS One 8: e56929, 2013.
6. Chung AC, Dong Y, Yang W, Zhong X, Li R, Lan HY. Smad7 suppresses renal fibrosis via altering expression of TGF-beta/Smad3- regulated microRNAs. Mol Ther 21: 388-398, 2013.
7. Drummond CA, Budny GV, Haller ST, Liu J, Yan Y, Xie JX, Malhotra D, Shapiro JI, Tian J. Gender differences in the development of uremic cardiomyopathy following partial nephrectomy: role of progesterone. J Hypertens 2: 109-117, 2013.
8. Drummond CA, Sayed M, Evans KL, Shi H, Wang X, Haller ST, Liu J, Cooper CJ, Xie Z, Shapiro JI, Tian J. Reduction of Na/K-ATPase affects cardiac remodeling and increases c-kit cell abundance in partial nephrectomized mice. Am J Physiol Heart Circ Physiol 306: H1631-H1643, 2014.
9. Elkareh J, Kennedy DJ, Yashaswi B, Vetteth S, Shidyak A, Kim EGR, Smaili S, Periyasamy SM, Hariri IM, Fedorova L, Liu J, Wu L, Kahaleh MB, Xie Z, Malhotra D, Fedorova OV, Kashkin VA, Bagrov AY, Shapiro JI. Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy. Hypertension 49: 215-224, 2007.
10. Elkareh J, Periyasamy SM, Shidyak A, Vetteth S, Schroeder J, Raju V, Hariri IM, El-Okdi N, Gupta S, Fedorova L, Liu J, Fedorova OV, Kahaleh MB, Xie Z, Malhotra D, Watson DK, Bagrov AY, Shapiro JI. Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy. Am J Physiol Renal Physiol 296: F1219-F1226, 2009.
11. Fendler A, Jung M, Stephan C, Erbersdobler A, Jung K, Yousef GM. The antiapoptotic function of miR-96 in prostate cancer by inhibition of FOXO1. PLoS One 8: e80807, 2013.
12. Garcia-Sastre A, Evans MJ. miR-122 is more than a shield for the hepatitis C virus genome. Proc Natl Acad Sci USA 110: 1571-1572, 2013.
13. Giunti L, da Ros M, Vinci S, Gelmini S, Iorio AL, Buccoliero AM, Cardellicchio S, Castiglione F, Genitori L, de Martino M, Giglio S, Genuardi M, Sardi I. Anti-miR21 oligonucleotide enhances chemosensitivity of T98G cell line to doxorubicin by inducing apoptosis. Am J Cancer Res 5: 231-242, 2015.
14. Haller ST, Drummond CA, Yan Y, Liu J, Tian J, Malhotra D, Shapiro JI. Passive immunization against marinobufagenin attenuates renal fibrosis and improves renal function in experimental renal disease. Am J Hypertens 27: 603-609, 2014.
15. Haller ST, Kennedy DJ, Shidyak A, Budny GV, Malhotra D, Fedorova OV, Shapiro JI, Bagrov AY. Monoclonal antibody against marinobufagenin reverses cardiac fibrosis in rats with chronic renal failure. Am J Hypertens 25: 690-696, 2012.
16. Huang Y, Tong J, He F, Yu X, Fan L, Hu J, Tan J, Chen Z. miR-141 regulates TGF-beta1-induced epithelial-mesenchymal transition through repression of HIPK2 expression in renal tubular epithelial cells. Int J Mol Med 35: 311-318, 2015.
17. Jalil JE, Doering CW, Janicki JS, Pick R, Shroff SG, Weber KT. Fibrillar collagen and myocardial stiffness in the intact hypertrophied rat left ventricle. Circ Res 64: 1041-1050, 1989.
18. Kennedy DJ, Vetteth S, Periyasamy SM, Kanj M, Fedorova L, Khouri S, Kahaleh MB, Xie Z, Malhotra D, Kolodkin NI, Lakatta EG, Fedorova OV, Bagrov AY, Shapiro JI. Central role for the cardiotonic steroid marinobufagenin in the pathogenesis of experimental uremic cardiomyopathy. Hypertension 47: 488-495, 2006.
19. Latronico MV, Condorelli G. Therapeutic use of microRNAs in myocardial diseases. Curr Heart Fail Rep 8: 193-197, 2011.
20. Li F, Mahato RI. Bipartite vectors for co-expression of a growth factor cDNA and short hairpin RNA against an apoptotic gene. J Gene Med 11: 764-771, 2009.
21. Li Z, Zhang Z, Xie JX, Li X, Tian J, Cai T, Cui H, Ding H, Shapiro JI, Xie Z. Na/K-ATPase mimetic pNaKtide peptide inhibits the growth of human cancer cells. J Biol Chem 286: 32394-32403, 2011.
22. Liang M, Cai T, Tian J, Qu W, Xie ZJ. Functional characterization of Src-interacting Na/K-ATPase using RNA interference assay. J Biol Chem 281: 19709-19719, 2006.
23. Liu S, Li W, Xu M, Huang H, Wang J, Chen X. Micro-RNA 21 targets dual specific phosphatase 8 to promote collagen synthesis in high glucosetreated primary cardiac fibroblasts. Can J Cardiol 30: 1689-1699, 2014.
24. Luo R, Shao X, Xu P, Liu Y, Wang Y, Zhao Y, Liu M, Ji L, Li YX, Chang C, Qiao J, Peng C, Wang YL. MicroRNA-210 contributes to preeclampsia by downregulating potassium channel modulatory factor 1. Hypertension 64: 839-845, 2014.
25. Montgomery RL, Yu G, Latimer PA, Stack C, Robinson K, Dalby CM, Kaminski N, van Rooij E. MicroRNA mimicry blocks pulmonary fibrosis. EMBO Mol Med 6: 1347-1356, 2014.
26. Nho RS, Im J, Ho YY, Hergert P. MicroRNA-96 inhibits FoxO3a function in IPF fibroblasts on type I collagen matrix. American J Physiol Lung Cell Mol Physiol 307: L632-L642, 2014.
27. Qin W, Chung AC, Huang XR, Meng XM, Hui DS, Yu CM, Sung JJ, Lan HY. TGF-beta/Smad3 signaling promotes renal fibrosis by inhibiting miR-29. J Am Soc Nephrol 22: 1462-1474, 2011.
28. Qu L, Liu A, Zhou L, He C, Grossman PH, Moy RL, Mi QS, Ozog D. Clinical and molecular effects on mature burn scars after treatment with a fractional CO(2) laser. Lasers Surg Med 44: 517-524, 2012.
29. Ramdas V, McBride M, Denby L, Baker AH. Canonical transforming growth factor-beta signaling regulates disintegrin metalloprotease expression in experimental renal fibrosis via miR-29. Am J Pathol 183: 1885-1896, 2013.
30. Rathore MG, Saumet A, Rossi JF, de Bettignies C, Tempe D, Lecellier CH, Villalba M. The NF-kappaB member p65 controls glutamine metabolism through miR-23a. Int J Biochem Cell Biol 44: 1448-1456, 2012.
31. Roubille F, Busseuil D, Merlet N, Kritikou EA, Rheaume E, Tardif JC. Investigational drugs targeting cardiac fibrosis. Exp Rev Cardiovasc Ther 12: 111-125, 2014.
32. Saltzman HE, Sharma K, Mather PJ, Rubin S, Adams S, Whellan DJ. Renal dysfunction in heart failure patients: what is the evidence? Heart Fail Rev 12: 37-47, 2007.
33. Scian MJ, Maluf DG, David KG, Archer KJ, Suh JL, Wolen AR, Mba MU, Massey HD, King AL, Gehr T, Cotterell A, Posner M, Mas V. MicroRNA profiles in allograft tissues and paired urines associate with chronic allograft dysfunction with IF/TA. Am J Transplant 11: 2110-2122, 2011.
34. Squillace N, Bresciani E, Torsello A, Bandera A, Sabbatini F, Giovannetti C, Giunta G, Rovati L, Del Bene M, Locatelli V, Gori A. Changes in subcutaneous adipose tissue microRNA expression in HIVinfected patients. J Antimicrob Chemother 69: 3067-3075, 2014.
35. Tian J, Cai T, Yuan Z, Wang H, Liu L, Haas M, Maksimova E, Huang XY, Xie ZJ. Binding of Src to Na/K-ATPase forms a functional signaling complex. Mol Biol Cell 17: 317-326, 2006.
36. Tijsen AJ, Creemers EE, Moerland PD, de Windt LJ, van der Wal AC, Kok WE, Pinto YM. MiR423-5p as a circulating biomarker for heart failure. Circ Res 106: 1035-1039, 2010.
37. Trenkmann M, Brock M, Gay RE, Michel BA, Gay S, Huber LC. Tumor necrosis factor alpha-induced microRNA-18a activates rheumatoid arthritis synovial fibroblasts through a feedback loop in NF-kappaB signaling. Arthritis Rheum 65: 916-927, 2013.
38. Tu X, Zhang H, Zhang J, Zhao S, Zheng X, Zhang Z, Zhu J, Chen J, Dong L, Zang Y, Zhang J. MicroRNA-101 suppresses liver fibrosis by targeting the TGFbeta signalling pathway. J Pathol 234: 46 -59, 2014.
39. Turczynska KM, Bhattachariya A, Sall J, Goransson O, Sward K, Hellstrand P, Albinsson S. Stretch-sensitive down-regulation of the miR-144/451 cluster in vascular smooth muscle and its role in AMPactivated protein kinase signaling. PLoS One 8: e65135, 2013.
40. van Rooij E, Olson EN. MicroRNA therapeutics for cardiovascular disease: opportunities and obstacles. Nat Rev Drug Discov 11: 860-872, 2012.
41. van Rooij E, Sutherland LB, Thatcher JE, DiMaio JM, Naseem RH, Marshall WS, Hill JA, Olson EN. Dysregulation of microRNAs after myocardial infarction reveals a role of miR-29 in cardiac fibrosis. Proc Natl Acad Sci USA 105: 13027-13032, 2008.
42. Veigaard C, Kjeldsen E. Exploring the genome-wide relation between copy number status and microRNA expression. Genomics 104: 271-278, 2014.
43. Wang M, Wang Y, Zang W, Wang H, Chu H, Li P, Li M, Zhang G, Zhao G. Downregulation of microRNA-182 inhibits cell growth and invasion by targeting programmed cell death 4 in human lung adenocarcinoma cells. Tumour Biol 35: 39-46, 2014.
44. Xiao F, Chen J, Lian C, Han P, Zhang C. Tumor necrosis factor-related apoptosis-inducing ligand induces cytotoxicity specific to osteosarcoma by microRNA response elements. Mol Med Rep 11: 739-745, 2015.
45. Xie Z, Askari A. Na()/K()-ATPase as a signal transducer. Eur J Biochem 269: 2434-2439, 2002.
46. Xu HF, Ding YJ, Zhang ZX, Wang ZF, Luo CL, Li BX, Shen YW, Tao LY, Zhao ZQ. MicroRNA21 regulation of the progression of viral myocarditis to dilated cardiomyopathy. Mol Med Rep 10: 161-168, 2014.
47. Xu R, Bi C, Song J, Wang L, Ge C, Liu X, Zhang M. Upregulation of miR-142-5p in atherosclerotic plaques and regulation of oxidized lowdensity lipoprotein-induced apoptosis in macrophages. Mol Med Rep 11: 3229-3234, 2015.
48. Yang CN, Deng YT, Tang JY, Cheng SJ, Chen ST, Li YJ, Wu TS, Yang MH, Lin BR, Kuo MY, Ko JY, Chang CC. MicroRNA-29b regulates migration in oral squamous cell carcinoma and its clinical significance. Oral Oncol 51: 170-177, 2015.
49. Yuchuan H, Ya D, Jie Z, Jingqiu C, Yanrong L, Dongliang L, Changguo W, Kuoyan M, Guangneng L, Fang X, Lanlan T, Bo Q. Circulating miRNAs might be promising biomarkers to reflect the dy- namic pathological changes in smoking-related interstitial fibrosis. Toxicol Ind Health 30: 182-191, 2014.
50. Zell S, Schmitt R, Witting S, Kreipe HH, Hussein K, Becker JU. Hypoxia induces mesenchymal gene expression in renal tubular epithelial cells: an in vitro model of kidney transplant fibrosis. Nephron Extra 3: 50-58, 2013.
51. Zhang Y, Fei M, Xue G, Zhou Q, Jia Y, Li L, Xin H, Sun S. Elevated levels of hypoxia-inducible microRNA-210 in pre-eclampsia: new insights into molecular mechanisms for the disease. J Cell Mol Med 16: 249-259, 2012.
52. Zhu G, Chai J, Ma L, Duan H, Zhang H. Downregulated microRNA-32 expression induced by high glucose inhibits cell cycle progression via PTEN upregulation and Akt inactivation in bone marrow-derived mesenchymal stem cells. Biochem Biophys Res Commun 433: 526 -531, 2013.
53. Zhu JN, Chen R, Fu YH, Lin QX, Huang S, Guo LL, Zhang MZ, Deng CY, Zou X, Zhong SL, Yang M, Zhuang J, Yu XY, Shan ZX. Smad3 inactivation and miR-29b upregulation mediate the effect of carvedilol on attenuating the acute myocardium infarction-induced myocardial fibrosis in rat. PLos One 8: e75557, 2013.